首页> 外文OA文献 >A let-7 microRNA-binding site polymorphism in 3′-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy

【2h】

A let-7 microRNA-binding site polymorphism in 3′-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy

机译：KRAS基因3'-Untranstated地区的Let-7 microRNA结合位点多态性预测野生型KRAS患者的反应，所述野生型KRAS患者用西妥昔单抗单药治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
W. Zhang; T. Winder; Y. Ning; A. Pohl; D. Yang; M. Kahn; G. Lurje; M.J. LaBonte; P.M. Wilson; M.A. Gordon; S. Hu-Lieskovan; D.J. Mauro; C. Langer; E.K. Rowinsky; H.-J. Lenz;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy. [J] . Zhang W, Winder T, Ning Y, Annals of oncology: official journal of the European Society for Medical Oncology . 2011,第1期

机译：KRAS基因3'-非翻译区的let-7 microRNA结合位点多态性预测西妥昔单抗单药治疗的野生型KRAS转移性结直肠癌患者的反应。
2. A let-7 microRNA-binding site polymorphism in 3′-untranslated region of KRAS gene predicts response in wild-type KRAS patientsn with metastatic colorectal cancer treated with cetuximab monotherapy [J] . H.-J. Lenz Annals of Oncology . 2011,第1期

机译：西妥昔单抗单药治疗的KRAS基因3'-非翻译区的let-7 microRNA结合位点多态性预测野生型KRAS转移性结直肠癌患者的反应
3. A let-7 microRNA-Binding Site Polymorphism in KRAS Predicts Improved Outcome in Patients with Metastatic Colorectal Cancer Treated with Salvage Cetuximab/ Panitumumab Monotherapy [J] . Zenia Saridaki, Joanne B. Weidhaas, Heinz-Josef Lenz, Clinical cancer research: an official journal of the American Association for Cancer Research . 2014,第17期

机译：KRAS中let-7 microRNA结合位点的多态性可预测西妥昔单抗/帕尼单抗单药治疗的转移性结直肠癌患者的转归改善。
4. Isolation of Circulating Tumor Cells from Patients with Metastatic Colorectal Cancer Using Label-Free Microfluidic Technology for Enumeration and Detection of KRAS, BRAF, PIK3CA Mutation [C] . Haiyan Emily Liu, Evelyn Kidess-Sigal, Melanie Triboulet, International Molecular Medicine Tri-Conference. . 2016

机译：使用无标记微流体技术分离转移性结肠直肠癌患者的循环肿瘤细胞进行募准和检测KRA，BRAF，PIK3CA突变
5. Evaluating response to treatment and predicting outcome in patients with metastatic colorectal carcinoma using statistical learning theory . [D] . Margolis, Daniel Eli. 2010

机译：运用统计学习理论评价转移性大肠癌患者的治疗反应和预测结局。
6. A let-7 microRNA-binding site polymorphism in KRAS predicts improved outcome in metastatic colorectal cancer (mCRC) patients treated with salvage cetuximab/panitumumab monotherapy [O] . Zenia Saridaki, Joanne B. Weidhaas, Heinz-Josef Lenz, -1

机译：KRAS的let-7 microRNA结合位点多态性预测接受挽救性西妥昔单抗/帕尼单抗单药治疗的转移性结直肠癌（mCRC）患者的转归改善
7. A let-7 microRNA-binding site polymorphism in KRAS predicts improved outcome in patients with metastatic colorectal cancer treated with salvage cetuximab/panitumumab monotherapy [O] . Saridaki, Zenia, Weidhaas, Joanne B., Lenz, Heinz-Josef, 2014

机译：KRAS中let-7 microRNA结合位点的多态性预测，接受挽救性西妥昔单抗/帕尼单抗单药治疗的转移性结直肠癌患者的预后改善

A let-7 microRNA-binding site polymorphism in 3′-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy

著录项

引文网络

相似文献

相关主题

期刊订阅